chmp - Robuta Search

https://www.onclive.com/view/chmp-recommends-adjuvant-t-dxd-for-her2-early-breast-cancer-with-residual-invasive-disease CHMP Recommends Adjuvant T-DXd for HER2+ Early Breast Cancer With Residual Invasive Disease |... Oct 10, 2026 - The CHMP recommended approval of adjuvant T-DXd for HER2-positive early breast cancer with residual invasive disease after neoadjuvant therapy. breast cancer chmp recommends adjuvant dxd https://www.pharmafocus.com/articles/chmp-gives-positive-opinion-for-merck-s-keytruda-for-unresectabl CHMP gives positive opinion for Merck’s KEYTRUDA for unresectable or metastatic urothelial carcinoma Sep 5, 2024 - Merck (known as msd outside of the us and canada) has announced that its anti-pd-1 therapy, in combination with padcev (enfortuman vedotin-ejfv), has recei urothelial carcinoma chmp gives positive opinion https://biopharmaboardroom.com/news/15/2893/astrazenecas-imfinzi-receives-positive-chmp-recommendation-for-limited-stage-small-cell-lung-cancer-treatment-in-the-eu.html AstraZeneca’s Imfinzi® Receives Positive CHMP Recommendation for Limited-Stage Small Cell Lung... AstraZeneca’s Imfinzi® Receives Positive CHMP Recommendation for Limited-Stage Small Cell Lung Cancer Treatment in the EU small cell receives positive chmp recommendation https://halmed.hr/Lijekovi/Za-pacijente/Novosti-o-sigurnoj-primjeni-lijekova/2016/CHMP-News-June-2016/1571 Novosti s CHMP-a - lipanj 2016. godine - Novosti o sigurnoj primjeni lijekova - Za pacijente |... Stranica donosi publikacije, izvješća i aktualne novosti vezane uz sigurnu primjenu lijekova, medicinskih proizvoda i homeopatskih lijekova te opisuje... novosti chmp lipanj godine https://www.astrazeneca.com/media-centre/press-releases/2026/camizestrant-recommended-for-breast-cancer-in-eu.html Camizestrant in combination with a CDK4/6 inhibitor recommended for approval in the EU by CHMP for... with a the eu camizestrant combination inhibitor https://www.achm.com.au/our-work/box-creek-weir/ Box Creek Weir | Complex CHMP and Burial Management | ACHM Sep 10, 2026 - Complex CHMP and burial investigation for Goulburn-Murray Water at Ghow (Kow) Swamp, with Ancestral remains dated to 12,500 years and protected in situ. box creek weir complex chmp https://www.biopharminternational.com/view/ema-s-chmp-adopts-positive-opinion-for-moderna-covid-19-vaccine-use-in-adolescents EMA’s CHMP Adopts Positive Opinion for Moderna COVID-19 Vaccine Use in Adolescents | BioPharm... Oct 14, 2026 - The EMA’s CHMP has adopted a positive opinion recommending marketing authorization for Moderna’s COVID-19 vaccine (Spikevax) to include adolescents 12 years of... chmp adopts positive opinion moderna https://newsmed.pl/leki/12180982/schemat-wyzszych-dawek-nusinersenu-otrzymal-pozytywna-opinie-chmp.html Schemat wyższych dawek nusinersenu otrzymał pozytywną opinię CHMP – NewsMed.pl Nov 20, 2025 - Firma Biogen Inc. ogłosiła, że Komitet ds. Produktów Leczniczych Stosowanych u Ludzi (CHMP) Europejskiej Agencji Leków (EMA) wydał pozytywną opinię,... schemat dawek chmp https://www.saluteh24.com/2025/12/12/obesita-via-libera-del-chmp-a-una-nuova-dose-di-semaglutide/ Obesità: via libera del CHMP a una nuova dose di semaglutide Il Comitato per i Medicinali per Uso Umano (CHMP) dell’Agenzia Europea per i Medicinali (EMA) ha espresso parere positivo per un dosaggio più elevato di... via libera del chmp una nuova https://www.myeloma.org/news-events/multiple-myeloma-news/chmp-positive-opinion-melflufen-lenalidomide-refractory-myeloma CHMP Positive Opinion on Melflufen | Int'l Myeloma Fn The CHMP of the European Medicines Agency gives positive opinion for Pepaxti (melflufen). chmp positive opinion melflufen int https://www.roche.com/investors/updates/inv-update-2022-12-16 CHMP recommends expansion of EU label for Hemlibra to include people with moderate haemophilia A The positive CHMP opinion is based on the results of the HAVEN 6 study, which demonstrated effective bleed control and a favourable safety profile of Hemlibra... expansion of eu chmp recommends label hemlibra https://www.astrazeneca.com/media-centre/press-releases/2026/trixeo-recommended-for-approval-in-the-eu-by-chmp-for-the-maintenance-treatment-of-asthma.html Trixeo recommended for approval in the EU by CHMP for the maintenance treatment of asthma treatment of asthma in the trixeo recommended approval https://menarini.es/notas-prensa/chmp-adopted-positive-opinion-for-elzonris-tagraxofusp-for-the-treatment-of-blastic-plasmacytoid-dendritic-cell-neoplasm-bpdcn/ CHMP Adopted Positive Opinion for ELZONRIS (tagraxofusp), for the Treatment of Blastic Plasmacytoid... Apr 8, 2022 - The CHMP recommended approval of ELZONRIS for the first line treatment of adult patients with BPDCN If approved by the European Commission, ELZONRIS will be... the treatment chmp adopted positive opinion https://www.vaccination-info-service.fr/Glossaire/CHMP CHMP | Vaccination Info Service Premier site institutionnel sur la vaccination en direction du grand public, vaccination-info-service apporte des informations factuelles, pratiques et... vaccination info service chmp https://www.financialexpress.com/business/healthcare-chmp-recommends-approval-of-abbvies-rinvoq-for-treatment-of-nr-asspa-2575702/ CHMP recommends approval of AbbVie’s Rinvoq for treatment of nr-asSpA - Healthcare News | The... Currently, Rinvoq approved for use in the EU in patients with moderate to severely active rheumatoid arthritis, active psoriatic arthritis, active ankylosing... chmp recommends approval rinvoq treatment https://www.biospace.com/gilead-and-galapagos-announce-positive-european-chmp-opinion-for-jyseleca-filgotinib-for-the-treatment-of-adults-with-moderate-to-severe-rheumatoid-arthritis Gilead and Galapagos Announce Positive European CHMP Opinion for Jyseleca® (Filgotinib) for the... Jul 24, 2020 - Gilead and Galapagos Announce Positive European CHMP Opinion for Jyseleca ® (Filgotinib) for the Treatment of Adults With Moderate to Severe Rheumatoid... gilead galapagos announce positive european https://www.pw.nl/nieuws/geneesmiddelennieuws/2026-10/chmp-advies-ocrelizumab-ook-inzetbaar-bij-kinderen-vanaf-10?pw_search_cat_and_type=Herexamen CHMP-advies: ocrelizumab ook inzetbaar bij kinderen vanaf 10 jaar | Pharmaceutisch Weekblad Door een positief oordeel van de Europese geneesmiddelenbeoordelingscommissie CHMP is ocrelizumab (Ocrevus) breder toepasbaar. chmp advies ocrelizumab ook inzetbaar https://pharmactu.fr/articles/chmp-septembre-2026-generiques-biosimilaires-xeljanz-xolair-jakavi Le CHMP valide de nouveaux gÃ©nÃ©riques et biosimilaires : Xeljanz, Xolair, Jakavi, Perjeta â€”... Sep 22, 2026 - Ã€ sa rÃ©union de septembre 2026, le comitÃ© des mÃ©dicaments Ã usage humain (CHMP) de l'Agence europÃ©enne des mÃ©dicaments a rendu un avis positif pour deux... chmp valide nouveaux xeljanz xolair https://www.becro.gr/ema-chmp-arbitration-procedures/ EMA/CHMP arbitration procedures - BECRO - CRO Greece - Contract Services Organization - Clinical... Nov 16, 2022 - EMA/CHMP arbitration procedures ema chmp arbitration procedures cro https://www.ecv.de/beitrag/pharmind/Aktivit%C3%A4ten_des_CHMP_052009 ECV: pharmind - Beitrag Aktivitäten des CHMP 05/2009 ecv beitrag des chmp https://farma7.it/chmp-dellema-via-libera-a-nuovi-farmaci/ Chmp dell’Ema: via libera a nuovi farmaci - Farma 7 : Farma 7 Oct 2, 2026 - Il Comitato per i medicinali per uso umano (Chmp) dell’Agenzia europea dei medicinali (Ema) ha espresso parere positivo per 12 […] via libera chmp nuovi farmaci